CTNM
Price
$4.43
Change
-$0.20 (-4.32%)
Updated
Jun 13 closing price
Capitalization
114.61M
66 days until earnings call
SLN
Price
$5.33
Change
-$0.26 (-4.65%)
Updated
Jun 13 closing price
Capitalization
212.54M
Interact to see
Advertisement

CTNM vs SLN

Header iconCTNM vs SLN Comparison
Open Charts CTNM vs SLNBanner chart's image
Contineum Therapeutics
Price$4.43
Change-$0.20 (-4.32%)
Volume$145.16K
Capitalization114.61M
Silence Therapeutics
Price$5.33
Change-$0.26 (-4.65%)
Volume$77.79K
Capitalization212.54M
CTNM vs SLN Comparison Chart
Loading...
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTNM vs. SLN commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTNM is a Hold and SLN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (CTNM: $4.43 vs. SLN: $5.33)
Brand notoriety: CTNM and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTNM: 135% vs. SLN: 37%
Market capitalization -- CTNM: $114.61M vs. SLN: $212.54M
CTNM [@Biotechnology] is valued at $114.61M. SLN’s [@Biotechnology] market capitalization is $212.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTNM’s FA Score shows that 1 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • CTNM’s FA Score: 1 green, 4 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, SLN is a better buy in the long-term than CTNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTNM’s TA Score shows that 5 TA indicator(s) are bullish while SLN’s TA Score has 3 bullish TA indicator(s).

  • CTNM’s TA Score: 5 bullish, 4 bearish.
  • SLN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CTNM is a better buy in the short-term than SLN.

Price Growth

CTNM (@Biotechnology) experienced а -6.74% price change this week, while SLN (@Biotechnology) price change was -2.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

CTNM is expected to report earnings on Aug 19, 2025.

SLN is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLN($213M) has a higher market cap than CTNM($115M). SLN YTD gains are higher at: -22.529 vs. CTNM (-69.761). CTNM has higher annual earnings (EBITDA): -42M vs. SLN (-71.65M). CTNM has more cash in the bank: 205M vs. SLN (137M). SLN has less debt than CTNM: SLN (60K) vs CTNM (6.26M). SLN has higher revenues than CTNM: SLN (27.7M) vs CTNM (0).
CTNMSLNCTNM / SLN
Capitalization115M213M54%
EBITDA-42M-71.65M59%
Gain YTD-69.761-22.529310%
P/E Ratio26.40N/A-
Revenue027.7M-
Total Cash205M137M150%
Total Debt6.26M60K10,432%
TECHNICAL ANALYSIS
Technical Analysis
CTNMSLN
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 12 days ago
71%
Bullish Trend 3 days ago
89%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWGPX26.43N/A
N/A
Nationwide WCM Focused Sm Cp A
ATECX105.86N/A
N/A
AB Sustainable Global Thematic C
PAILX8.20N/A
N/A
PGIM Jennison Intl Sm-Md Cap Opps C
NYVBX19.51-0.24
-1.22%
Davis NY Venture B
AILCX16.83-0.26
-1.52%
American Beacon International Eq C

CTNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTNM has been loosely correlated with CCCC. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CTNM jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
-4.32%
CCCC - CTNM
37%
Loosely correlated
+3.70%
VYGR - CTNM
31%
Poorly correlated
-8.33%
XNCR - CTNM
30%
Poorly correlated
-2.55%
ADCT - CTNM
30%
Poorly correlated
-2.45%
SLN - CTNM
29%
Poorly correlated
-4.57%
More

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
-4.57%
CLLS - SLN
43%
Loosely correlated
-2.69%
CMVLF - SLN
38%
Loosely correlated
N/A
ANNX - SLN
37%
Loosely correlated
-8.12%
IDYA - SLN
37%
Loosely correlated
-0.45%
ABCZF - SLN
36%
Loosely correlated
N/A
More